These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25076291)

  • 41. Evaluation of Performance of Laboratories and Manufacturers Within the Framework of the IFCC model for Quality Targets of HbA1c.
    Weykamp C; Siebelder C
    J Diabetes Sci Technol; 2018 Jul; 12(4):747-752. PubMed ID: 29145735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and effect of hemoglobin E disorders on Hba1c and lipid profile of diabetic patients at Surin Hospital.
    Srisurin W
    J Med Assoc Thai; 2011 Jan; 94(1):36-42. PubMed ID: 21425726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical informatics to improve quality of care: a population-based system for patients with diabetes mellitus.
    Chaudhry R; Tulledge-Scheitel SM; Thomas MR; Hunt VL; Liesinger JT; Rahman AS; Naessens JM; Davis LA; Stroebel RJ
    Inform Prim Care; 2009; 17(2):95-102. PubMed ID: 19807951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycated hemoglobin standardization--National Glycohemoglobin Standardization Program (NGSP) perspective.
    Little RR
    Clin Chem Lab Med; 2003 Sep; 41(9):1191-8. PubMed ID: 14598869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycated hemoglobin: A powerful tool not used enough in primary care.
    Salinas M; López-Garrigós M; Flores E; Leiva-Salinas C;
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28857364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: prevalence and patient characteristics.
    Greiver M; Aliarzadeh B; Moineddin R; Meaney C; Ivers N
    BMC Fam Pract; 2011 Aug; 12():91. PubMed ID: 21864396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy.
    Ujihara N; Sakka Y; Takeda M; Hirayama M; Ishii A; Tomonaga O; Babazono T; Takahashi C; Yamashita K; Iwamoto Y
    Diabetes Res Clin Pract; 2002 Nov; 58(2):109-14. PubMed ID: 12213352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes.
    Wetzler HP; Snyder JW
    Diabetes Care; 2000 Nov; 23(11):1637-41. PubMed ID: 11092285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?
    O'Sullivan CJ; Hynes N; Mahendran B; Andrews EJ; Avalos G; Tawfik S; Lowery A; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Aug; 32(2):188-97. PubMed ID: 16580235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic effect of following HbA1c testing practice guidelines in the elderly Medicare population: an instrumental variable analysis.
    Li S; Liu J; Gilbertson DT; Collins AJ
    Am J Med Qual; 2010; 25(3):202-10. PubMed ID: 20110455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiative.
    Chalasani S; Peiris DP; Usherwood T; Redfern J; Neal BC; Sullivan DR; Colagiuri S; Zwar NA; Li Q; Patel A
    Med J Aust; 2017 Jun; 206(10):436-441. PubMed ID: 28566070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of glycemia in diabetes mellitus: hemoglobin A1c.
    Saudek CD; Kalyani RR; Derr RL
    J Assoc Physicians India; 2005 Apr; 53():299-305. PubMed ID: 15987016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of point-of-care and over-the-counter testing methods for hemoglobin A1c: how good do they need to be?
    Little RR
    J Diabetes Sci Technol; 2010 Nov; 4(6):1504-6. PubMed ID: 21129347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of HbA1c in management of diabetes mellitus.
    Al-Ghamdi AA
    Saudi Med J; 2004 Mar; 25(3):342-5. PubMed ID: 15048173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physicians' practices in screening for the development of diabetic nephropathy and the use of glycosylated hemoglobin levels.
    Miller KL; Hirsch IB
    Diabetes Care; 1994 Dec; 17(12):1495-7. PubMed ID: 7882826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review.
    Marincic PZ; Salazar MV; Hardin A; Scott S; Fan SX; Gaillard PR; Wyatt C; Watson L; Green P; Glover P; Hand M
    J Acad Nutr Diet; 2019 Mar; 119(3):449-463. PubMed ID: 30219311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c.
    Saudek CD; Derr RL; Kalyani RR
    JAMA; 2006 Apr; 295(14):1688-97. PubMed ID: 16609091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contributions of Glucose and Hemoglobin A1c Measurements in Diabetes Screening.
    Hilborne LH; Bi C; Radcliff J; Kroll MH; Kaufman HW
    Am J Clin Pathol; 2022 Jan; 157(1):1-4. PubMed ID: 34463337
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.